HomeCompareONEM vs MRK

ONEM vs MRK: Dividend Comparison 2026

ONEM yields 12.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $12.2K in total portfolio value· pulled ahead in Year 9
10 years
ONEM
ONEM
● Live price
12.14%
Share price
$16.47
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,589.86
Full ONEM calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ONEM vs MRK

📍 MRK pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodONEMMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ONEM + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ONEM pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ONEM
Annual income on $10K today (after 15% tax)
$1,032.18/yr
After 10yr DRIP, annual income (after tax)
$2,201.38/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $6,127.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ONEM + MRK for your $10,000?

ONEM: 50%MRK: 50%
100% MRK50/50100% ONEM
Portfolio after 10yr
$50.7K
Annual income
$6,194.00/yr
Blended yield
12.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ONEM
Analyst Ratings
8
Buy
12
Hold
Consensus: Hold
Price Target
$16.00
-2.9% upside vs current
Range: $10.00 — $25.00
Altman Z
1.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ONEM buys
0
MRK buys
0
No recent congressional trades found for ONEM or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricONEMMRK
Forward yield12.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$44.5K$56.8K
Annual income after 10y$2,589.86$9,798.13
Total dividends collected$18.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$16.00$128.54

Year-by-year: ONEM vs MRK ($10,000, DRIP)

YearONEM PortfolioONEM Income/yrMRK PortfolioMRK Income/yrGap
1$11,914$1,214.33$11,206$366.19+$708.00ONEM
2$14,100$1,352.14$12,650$502.35+$1.4KONEM
3$16,583$1,495.56$14,407$694.19+$2.2KONEM
4$19,388$1,643.80$16,585$967.82+$2.8KONEM
5$22,541$1,796.09$19,342$1,363.89+$3.2KONEM
6$26,070$1,951.59$22,913$1,947.19+$3.2KONEM
7$30,005$2,109.51$27,662$2,823.89+$2.3KONEM
8$34,374$2,269.03$34,159$4,173.35+$215.00ONEM
9← crossover$39,210$2,429.40$43,337$6,308.80$4.1KMRK
10$44,544$2,589.86$56,776$9,798.13$12.2KMRK

ONEM vs MRK: Complete Analysis 2026

ONEMStock

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.

Full ONEM Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ONEM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ONEM vs SCHDONEM vs JEPIONEM vs OONEM vs KOONEM vs MAINONEM vs JNJONEM vs ABBVONEM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.